Associated Papers
The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers.
Zhang Y et al.
Nature Communications, 2022
35650238 (PubMed )
Supplement: 41467_2022_30708_MOESM1_ESM.pdf
ROBO1 p.E280* Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal.
Zhou T et al.
Frontiers in Oncology, 2022
35615148 (PubMed )
Supplement: DataSheet_1.xlsx › Sheet1
Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.
Roberti A et al.
Nature Communications, 2016
27600764 (PubMed )
Supplement: ncomms12602-s2.xlsx › Supplementary_Data_2
Select a paper to view details